Phase I Trial of Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
Phase of Trial: Phase I
Latest Information Update: 07 Jan 2019
At a glance
- Drugs Ribociclib (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 28 Aug 2018 Status changed from suspended to recruiting.
- 07 Jun 2018 Planned number of patients changed from 40 to 42.